FAIRFIELD, Conn.--(BUSINESS WIRE)--Calmare Therapeutics Incorporated, (OTC:CTTC) (CTI), the pain mitigation company, reported results for the year and quarter ended December 31, 2014.
Year Ended December 31, 2014
Revenue from the sale and shipment of the Calmare® pain therapy devices (Devices) for the year ended December 31, 2014 increased 60% or $392,000 to $1,045,000 as compared with $653,000 for the year-ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
Year Ended December 31, 2014
Revenue from the sale and shipment of the Calmare® pain therapy devices (Devices) for the year ended December 31, 2014 increased 60% or $392,000 to $1,045,000 as compared with $653,000 for the year-ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
